FLUARIX susp inj ser préremp 15 µg 10 pce

7680700420044 CH-70042 J07BB02 08.08.

No images available

Details

Product number
7004202
CPT
-
Packaging group
10
Unit
Fertigspritze(n)
Composition
haemagglutininum influenzae A (H1N1) (Virus Stamm A/Missouri/11/2025 (H1N1)pdm09-like: reassortant virus IVR-278 derived from A/Switzerland/6849/2025) 15 µg, haemagglutininum influenzae A (H3N2) (Virus Stamm A/Darwin/1454/2025 (H3N2)-like: reassortant virus SAN-049A derived from A/Michigan/105/2025) 15 µg, haemagglutininum influenzae B (Virus Stamm B/Tokyo/EIS13-175/2025-like: B/Tokyo/EIS13-175/2025, wild type (Victoria lineage)) 15 µg, polysorbatum 80 max. 415 µg, octoxinolum-10, natrii chloridum, magnesii chloridum hexahydricum, dinatrii phosphas dodecahydricus, kalii dihydrogenophosphas, kalii chloridum, alpha-tocopheroli hydrogenosuccinas, aqua ad iniectabile q.s. ad suspensionem pro 0.5 ml corresp. natrium 1.7 mg, kalium 0.1 mg, residui: ovalbuminum, formaldehydum, natrii desoxycholas, gentamicini sulfas, hydrocortisonum.

Articles (1)

Fluarix, Injektionssuspension
Injektionssuspension
10
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
29/11/2025
Professional SmPC
Français
29/11/2025
Professional SmPC
Italien
29/11/2025

Detailed composition

Substance Quantity Type Category
haemagglutininum influenzae A (H1N1)
15.0 UG Substance Wirkstoff (Principe actif)
haemagglutininum influenzae A (H3N2)
15.0 UG Substance Wirkstoff (Principe actif)
haemagglutininum influenzae B
15.0 UG Substance Wirkstoff (Principe actif)
polysorbatum 80
- Substance HBESI
octoxinolum-10
- Substance HNIDK
natrii chloridum
- Substance HNIDK
magnesii chloridum hexahydricum
- Substance HNIDK
dinatrii phosphas dodecahydricus
- Substance HNIDK
kalii dihydrogenophosphas
- Substance HNIDK
kalii chloridum
- Substance HNIDK
alpha-tocopheroli hydrogenosuccinas
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
1.7 MG Substance HBESI
kalium
0.1 MG Substance HBESI
ovalbuminum
- Substance RESI
formaldehydum
- Substance RESI
natrii desoxycholas
- Substance RESI
gentamicini sulfas
- Substance RESI
hydrocortisonum
- Substance RESI

Authorization holder

GlaxoSmithKline AG

6340 Baar

Authorization information

Swissmedic authorization number
70042
Drug name
Fluarix, Injektionssuspension
Galenic form
INJFS
ATC Code
J07BB02
Authorization status
Z
Dispensation category
B
First authorization
04/09/2025
Authorization expiration date
03/09/2030
IT number
08.08.
Domain
Human medicine
Field of application
aktive Immunisierung gegen Influenza von Erwachsenen und Kindern ab 6 Monaten

Packaging details

Description (FR)
FLUARIX susp inj ser préremp 15 µg 10 pce
Description (DE)
FLUARIX Inj Susp Fertspr 15 µg 10 Stk
Market launch
01/09/2026
Narcotic (BTM)
No

Other packaging sizes

FLUARIX susp inj ser préremp 15 µg 1 pce
1 FESP
View
FLUARIX susp inj ser préremp 15 µg 10 pce
10 FESP
View
FLUARIX susp inj ser préremp 15 µg 1 pce
1 FESP
View
Buy us a coffee Explore the data